References

Beebe T, Jacobson R, Jenkins S, Lackore K, Rutten L. Testing the impact of mixed-mode designs (mail and web) and multiple contact attempts within mode (mail or web) on clinician survey response. 2020; https://doi.org/10.1111/1475-6773.12827

Brown K, Ridout D, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart. 2006; 92:(9)1298-1302 https://doi.org/10.1136/hrt.2005.078097

Ewer A, Middleton L, Furmston A, Bhoyar A, Daniels J, Thangaratinam S, Deeks J, Khan K. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. The Lancet. 2011; 378:(9793)785-794 https://doi.org/10.1016/S0140-6736(11)60753-8

Ewer A. Pulse oximetry screening: do we have enough evidence now?. The Lancet. 2014; 384:(9945)725-726 https://doi.org/10.1016/S0140-6736(14)60575-4

Newborn pulse oximetry screening pilot update – PHE screening. 2017. https://phescreening.blog.gov.uk/2017/01/10/newborn-pulse-oximetry-screening-pilot-update/ (accessed 12 July 2019)

Jawin V, Ang H, Omar A, Thong M. Beyond critical congenital heart disease: newborn screening using pulse oximetry for neonatal sepsis and respiratory diseases in a middle-income country. PLOS ONE. 2015; 10:(9) https://doi.org/10.1371/journal.pone.0137580

UpToDate. 2019. https://www.uptodate.com/contents/newborn-screening (accessed 11 August 2019)

Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Medical Devices: Evidence and Research. 2014; https://doi.org/10.2147/MDER.S47319

Plana M, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer A. Pulse oximetry screening for critical congenital heart defects. Cochrane Database of Systematic Reviews. 2018; https://doi.org/10.1002/14651858.CD011912.pub2

Infant journal – planning and implementation of a pulse oximetry screening programme. 2016. http://www.infantjournal.co.uk/journal_article.html?RecordNumber=6869 (accessed 26 January 2020)

Socscistatistics.com. Wilcoxon Signed-Rank Test Calculator. 2019. https://www.socscistatistics.com/tests/signedranks/Default2.aspx (accessed 12 July 2019)

Thangaratinam S, Brown K, Zamora J, Khan K, Ewer A. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. The Lancet. 2012; 379:(9835)2459-2464 https://doi.org/10.1016/S0140-6736(12)60107-X

Uzun O, Kennedy J, Davies C, Goodwin A, Thomas N, Rich D, Thomas A, Tucker D, Beattie B, Lewis M. Training: improving antenatal detection and outcomes of congenital heart disease. BMJ Open Quality. 2018; 7:(4) https://doi.org/10.1136/bmjoq-2017-000276

Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Archives of Disease in Childhood – Fetal and Neonatal Edition. 2008; 93:(1)F33-F35 https://doi.org/10.1136/adc.2007.119032

Acceptability of newborn pulse oximetry screening

02 August 2020
10 min read
Volume 28 · Issue 8

Abstract

Aim

The aim of this study was to determine the acceptance of the midwives regarding the use of newborn pulse oximetry screening (NPOS) over a four-year period in a UK tertiary maternity unit.

Methods

An electronic survey of 10 questions was emailed to all midwives working in the maternity unit. Feedback was requested on their experience of performing NPOS using a feasibility scale (1=easy to 10=difficult). Other qualitative feedback explored the perceived usefulness and recollection of positive screening outcomes. The collated feedback was analysed using Wilcoxon Signed Rank test.

Results

Complete responses were received from 99 of 236 (42%) midwives. The average scale rankings of 3.46 (pre-introduction) and 2.38 (post-introduction) indicates that the responding midwives were positive about NPOS (z=-4.5575; p<0.001) and 99% (n=98) felt it was an important screening tool. Of the midwives, 38 (39%) had at least one positive screening result. Conditions identified included cardiac anomalies, sepsis and diaphragmatic hernia.

Conclusion

Our single-centre survey suggests that the NPOS has been well accepted by the midwifery staff in this maternity unit.

Congenital heart disease (CHD) is the general medical term for heart defects that are present from birth. CHD accounts for up to 10% of neonatal deaths and up to 40% of all infant deaths when left undiagnosed (Thangaratinam et al, 2012). The incidence rate for CHD in the UK is estimated to be 7/1 000, or one in every 145 babies born (Brown et al, 2006; Thangaratinam et al, 2012). The term critical congenital heart disease (CCHD) refers to a subgroup of CHD (25%) which can cause serious and life-threatening problems including cardiac arrest and death. Infants with CCHD (Table 1) require surgery or other procedures within the first 28 days of life to ensure survival (Wren et al, 2008; Thangaratinam et al, 2012).

Register now to continue reading

Thank you for visiting British Journal of Midwifery and reading some of our peer-reviewed resources for midwives. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • Unlimited access to the latest news, blogs and video content

  • Monthly email newsletter